ClinConnect ClinConnect Logo
Search / Trial NCT05292521

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

Launched by ROSWELL PARK CANCER INSTITUTE · Mar 22, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a special program to improve quality of life can help patients with early-stage lung cancer make better decisions about their treatment. Specifically, it focuses on patients who can choose between having surgery or a type of radiation therapy called stereotactic body radiation therapy (SBRT). The goal is to provide patients with helpful information about how each option might affect their quality of life, which may lead to less regret about their choices and greater satisfaction with their care.

To participate in this study, you need to be at least 18 years old and diagnosed with stage I or II non-small cell lung cancer, which is a common type of lung cancer. You must be eligible for both surgery and SBRT and able to understand and sign consent forms in English. If you join, you can expect to receive information that may help you feel more confident in making your treatment decision. It’s important to note that this trial is currently recruiting participants, and it excludes those with more advanced lung cancer or other specific conditions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \>= 18 years
  • Radiographic stage I-II non-small cell lung cancer (NSCLC)
  • Eligible for both surgery and SBRT
  • Able to provide informed consent in English
  • Have verbal fluency in English
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure
  • Exclusion Criteria:
  • Radiographic stage III-IV NSCLC
  • Eligible for either only surgery or SBRT, but not both
  • Eligible for palliative-intent treatments or supportive care only.
  • Pregnant female participants.
  • Unwilling or unable to follow protocol requirements
  • Any condition which in the investigator's opinion deems the participant an unsuitable candidate
  • Cognitively impaired adults/adults with impaired decision-making capacity
  • Individuals who are not yet adults (infants, children, teenagers)
  • Prisoners

About Roswell Park Cancer Institute

Roswell Park Cancer Institute is a leading biomedical research and treatment center dedicated to advancing cancer care through innovative research, education, and patient-centered clinical services. Established in 1898, it is recognized for its pioneering contributions to cancer research and treatment, making significant strides in immunotherapy, precision medicine, and cancer prevention. With a commitment to translating scientific discoveries into effective therapies, Roswell Park conducts a wide range of clinical trials aimed at improving outcomes for cancer patients. Its multidisciplinary team of experts collaborates to provide comprehensive care while fostering an environment of discovery and hope for patients and their families.

Locations

Buffalo, New York, United States

Patients applied

0 patients applied

Trial Officials

Anurag K Singh

Principal Investigator

Roswell Park Cancer Institute

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials